Fast Five Quiz: HIV Infection and Inflammation

Michael Stuart Bronze, MD; Enrico Brunetti, MD


August 10, 2023

Significant improvements in inflammatory biomarkers were induced by an integrase inhibitor-based regimen compared with a non-nucleoside reverse transcriptase inhibitor-based regimen. This favorable effect on immune activation may affect vascular inflammation. However, it is unknown whether these benefits are linked to clinical outcomes.

Learn more about ART integrase inhibitor-based regimens.

Editor's Recommendations


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.